Active Recombinant Full Length Human CDK9 Protein, GST-tagged
Cat.No. : | CDK9-8407HF |
Product Overview : | Full-length human CDK9 [1-372(end) amino acids of accession number NP_001252.1] was co-expressed as N-terminal GST-fusion protein (70 kDa) with His-CyclinT2(CCNT2) [1-730(end) amino acids of accession number NP_490595.1] using baculovirus expression system. GST-CDK9 was purified by using glutathione sepharose chromatography. |
- Specification
- Gene Information
- Related Products
- Download
Source : | Insect (sf21) |
Species : | Human |
Tag : | GST |
Form : | 50 mM Tris-HCl, 150 mM NaCl, 0.05% Brij35, 1 mM DTT, 10% glycerol, pH7.5 |
Bio-activity : | The activity was measured by off-chip mobility shift assay(MSA). The enzyme was incubated with fluorecence-labeled substrate and Mg(or Mn)/ATP. The phosphorylated and unphosphorylated substrates were separated and detected by MSA device. |
Protein length : | 1-372(end) |
Purity : | 77% |
Applications : | SDS-PAGE |
Storage : | Store at -80C. Avoid repeating freeze-thaws. |
Gene Name : | cyclin-dependent kinase 9 |
Official Symbol : | CDK9 |
Synonyms : | CDK9;C-2k;CDC2L4;CTK1;PITALRE;TAK |
Protein Refseq : | NP_001252.1 |
UniProt ID : | P50750 |
Products Types
◆ Recombinant Protein | ||
CDK9-1040H | Recombinant Human CDK9 Protein, GST-Tagged | +Inquiry |
CDK9-1042H | Recombinant Human CDK9/CycT1 Complex Protein, His/GST-tagged | +Inquiry |
CDK9-617R | Recombinant Rhesus Macaque CDK9 Protein, His (Fc)-Avi-tagged | +Inquiry |
CDK9-967R | Recombinant Rat CDK9 Protein, His (Fc)-Avi-tagged | +Inquiry |
CDK9-1449H | Recombinant Human CDK9 Protein (Asp104-Phe315), N-His tagged | +Inquiry |
◆ Lysates | ||
CDK9-178HCL | Recombinant Human CDK9 lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionBesides cancer and antiviral therapies, CDK9 is being explored for its role in other diseases, including neurodegenerative disorders.
Yes, combination therapies involving CDK9 inhibitors and other drugs are being investigated to enhance treatment outcomes.
CDK9 expression tends to increase as cancer progresses, suggesting its potential as a biomarker for disease severity.
CDK9 inhibitors can impact normal cell functions, leading to potential side effects such as myelosuppression.
Yes, several clinical trials are exploring the effectiveness of CDK9 inhibitors in different cancer types.
Customer Reviews (3)
Write a reviewIts remarkable quality, versatility, and the manufacturer's commitment to customer satisfaction make it the perfect choice for researchers seeking a premier protein that will undoubtedly enhance their experimental endeavors.
In addition to its remarkable quality and exceptional technical support, the CDK9 Protein boasts an impressive range of applications.
The CDK9 Protein has exceeded my expectations by consistently delivering outstanding results and providing exceptional technical support.
Ask a Question for All CDK9 Products
Required fields are marked with *
My Review for All CDK9 Products
Required fields are marked with *
Inquiry Basket